Skip to main content
OpenTrials
Completed

NCT Number: NCT04417374

Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.

On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.

By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.

It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.

This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID 19 COVID-19 Coronaviridae Infections Coronavirus Infections Disease Outbreak Infections Lung Diseases Mental Disorders Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University hospital

Montpellier, 34295, France

About this study

The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.

Secondary objectives :

  • Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
  • Assess the lengh of the hospitalization
  • Assess the number of patients hospitalized without psychiatric antecedent
  • Assess the number of treatment interruptions in the recent history before hospitalization
  • Asses the number of patients living alone
  • Asses the number of patients using drugs

It is expected to highlight :

  • An increase of the number of unvontuntary commitment
  • If one or several mental disorders were more at risk of requiring an unvonluntary commitment
  • An increased lengh of hospitalization
  • An increased number of unvonluntary commitment of patients without psychiatric antecedent
  • An increased number of treatment interruptions
  • A link between hospitalization and living alone
  • A link between hospitalization and using drugs

The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.

The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).

Exclusion criteria

  • refusal to participate

Treatment and study plan

Description of groups caracteristics

Other

Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Primary outcomes

  1. Number of hospitalized patients

    Time frame: 1 months

    Number of hospitalized patients From March 12th to April 09th

Secondary outcomes

  1. Cause of hospitalization

    Time frame: 1 months

    Primary psychiatric diagnostic From March 12th to April 09th

Other outcomes

  1. Lengh of hospitalization

    Time frame: 1 months

    Patients without psychiatric antecedent (number) From March 12th to April 09th

  2. Treatment interruption

    Time frame: 1 months

    Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th

  3. Number of hospitalized patients living alone

    Time frame: 1 months

    Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th

  4. Use of drugs

    Time frame: 1 months

    Number of patients using drugs From March 12th to April 09th

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context

Acronym: HoCoPsy

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 4, 2020
Registry last updated
Jul 29, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.